Literature DB >> 24418082

Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.

Dong Wang1, Xiang Li2, Jing Liu3, Jun Li3, Li-Jun Li3, Ming-Xing Qiu3.   

Abstract

OBJECTIVE: To study the expression of TRPC6 among prostate cancer cells, establish high expression cell lines of TRPC6, and to provide potential cell mode for prostate cancer oncogenesis and development.
METHODS: Occurrence and development of prostate cancer cells, PC3, PC-3 m DU145, 22 rv1, LNCaP and normal prostate epithelial cells in the PrEC TRPC6 expression level were detected by QPCR method. Calcium phosphate transfection method was used to package retrovirus pLEGFP-N1-TRPC6 and pLEGFP-N1-vector and infect the prostate cancer cells, a stable high expression of TRPC6 prostate cancer cells. Sable cell lines of TRPC6, matrix metalloproteinase (MMP) 2, MMP9 expression was detected by QPCR and Western blot. Change of cell invasion ability was detected by Transwell.
RESULTS: The expression level of prostate cancer cells TRPC6 were higher than control group PrEC cells. Among TPRC6 the expression of cell line PC 3 transfer potential wre the lowest, and high transfer cell line PC-3M express was the highest. Real-time fluorescent quantitative PCR and western blot results showed that after filter, the seventh generation of cell TRPC6 protein and mRNA expression levels were higher than the control group obviously. Transwell experimental results showed that the overexpression of TRPC6 could promote the invasion ability of PC3 prostate cancer cells.
CONCLUSIONS: TRPC6 expressed in prostate cancer cells is in disorder, and its action may be associated with the invasion and metastasis of prostate cancer cells; successful establishment of stable high expression of TRPC6 prostate cancer cells primarily confirm the invasion-trigger ability of TRPC6 on prostate cancer, and lay down the Foundation for exploring the TRPC6's role in the occurrence and development of prostate cancer mechanism.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prostate cancer; Retroviruses; Stable cell line; TRPC6; invasion

Mesh:

Substances:

Year:  2014        PMID: 24418082     DOI: 10.1016/S1995-7645(13)60190-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  6 in total

Review 1.  Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons.

Authors:  Giorgio Santoni; Claudio Cardinali; Maria Beatrice Morelli; Matteo Santoni; Massimo Nabissi; Consuelo Amantini
Journal:  J Neuroinflammation       Date:  2015-02-03       Impact factor: 8.322

Review 2.  Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms.

Authors:  Juan A Ardura; Luis Álvarez-Carrión; Irene Gutiérrez-Rojas; Verónica Alonso
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 3.  Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6.

Authors:  Giuseppe A Ramirez; Lavinia A Coletto; Clara Sciorati; Enrica P Bozzolo; Paolo Manunta; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Cells       Date:  2018-07-04       Impact factor: 6.600

Review 4.  Deciphering the Role of Ca2+ Signalling in Cancer Metastasis: From the Bench to the Bedside.

Authors:  Abeer Alharbi; Yuxuan Zhang; John Parrington
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

5.  Shenfu Injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression.

Authors:  Zhu-Jun Mao; Quan-Long Zhang; Jia Shang; Ting Gao; Wen-Jun Yuan; Lu-Ping Qin
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

Review 6.  The Role of TRP Channels in the Metastatic Cascade.

Authors:  Benedikt Fels; Etmar Bulk; Zoltán Pethő; Albrecht Schwab
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.